Cargando…

Clinical validation of genomic functional screen data: Analysis of observed BRCA1 variants in an unselected population cohort

Functional assessment of genomic variants provides a promising approach to systematically examine the potential pathogenicity of variants independent of associated clinical data. However, making such conclusions requires validation with appropriate clinical findings. To this end, here, we use varian...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schiabor Barrett, Kelly M., Masnick, Max, Hatchell, Kathryn E., Savatt, Juliann M., Banet, Natalie, Buchanan, Adam, Willard, Huntington F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804171/ https://www.ncbi.nlm.nih.gov/pubmed/35128484 http://dx.doi.org/10.1016/j.xhgg.2022.100086

Ejemplares similares

Testing and Management of Iron Overload After Genetic Screening–Identified Hemochromatosis
por: Savatt, Juliann M., et al.
Publicado: (2023)

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
por: Li, Jingmei, et al.
Publicado: (2018)

Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan
por: Muhammad, Noor, et al.
Publicado: (2023)

Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort
por: Liu, Yun, et al.
Publicado: (2021)

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
por: Kalachand, Roshni D., et al.
Publicado: (2020)

Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients
por: Zhong, Xiaorong, et al.
Publicado: (2016)

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece
por: Koumpis, Chrissovaladis, et al.
Publicado: (2011)

Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation
por: Pujol, Pascal, et al.
Publicado: (2022)

Genetic Testing in Neurodevelopmental Disorders
por: Savatt, Juliann M., et al.
Publicado: (2021)

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
por: Chen-Shtoyerman, R, et al.
Publicado: (2001)

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia
por: Hernández, Julián Esteban Londoño, et al.
Publicado: (2014)

Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
por: Buchanan, Adam H, et al.
Publicado: (2017)

Observational study of population genomic screening for variants associated with endocrine tumor syndromes in a large, healthcare-based cohort
por: Savatt, Juliann M., et al.
Publicado: (2022)

Correction to: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
por: Buchanan, Adam H., et al.
Publicado: (2021)

Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer
por: Chen, Bo, et al.
Publicado: (2020)

Cancer risk in relatives of BRCA1/2 pathogenic variant carriers in a large series of unselected patients with breast cancer
por: Liu, Jiaming, et al.
Publicado: (2023)

Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
por: Wen, Wei Xiong, et al.
Publicado: (2018)

Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic
por: Winter, C., et al.
Publicado: (2016)

Experience Completing Population Screening for Variants Associated With Endocrine Tumor Syndromes in a Large, Healthcare-Based Cohort
por: Savatt, Juliann M, et al.
Publicado: (2021)

Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk
por: Padmanabhan, Heamanthaa, et al.
Publicado: (2022)

Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience
por: Van der Merwe, Nerina C., et al.
Publicado: (2022)

Germline pathogenic variants in unselected Korean men with prostate cancer
por: So, Min-Kyung, et al.
Publicado: (2022)

Exome Sequencing–Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants
por: Manickam, Kandamurugu, et al.
Publicado: (2018)

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy
por: Cruz, Cristina, et al.
Publicado: (2018)

BRCA1/2 mutations, including large genomic rearrangements, among unselected ovarian cancer patients in Korea
por: Kim, Do-Hoon, et al.
Publicado: (2018)

Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population
por: van den Broek, Alexandra J, et al.
Publicado: (2015)

PALB2 variants in hereditary and unselected Finnish Prostate cancer cases
por: Pakkanen, Sanna, et al.
Publicado: (2009)

Variants of in situ carcinoma of the endometrium: Clear cell and gastrointestinal types, with a review of the literature
por: Abada, Evi, et al.
Publicado: (2022)

Pediatric reporting of genomic results study (PROGRESS): a mixed-methods, longitudinal, observational cohort study protocol to explore disclosure of actionable adult- and pediatric-onset genomic variants to minors and their parents
por: Savatt, Juliann M., et al.
Publicado: (2020)

Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma
por: Fountzilas, Elena, et al.
Publicado: (2021)

Yield of clinically reportable genetic variants in unselected cerebral palsy by whole genome sequencing
por: van Eyk, C. L., et al.
Publicado: (2021)

Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory
por: Strom, Charles M., et al.
Publicado: (2015)

Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer
por: Wan, Qiting, et al.
Publicado: (2021)

Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases
por: Armaou, S, et al.
Publicado: (2009)

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2017)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models
por: Hart, Steven N., et al.
Publicado: (2018)

A study of elective genome sequencing and pharmacogenetic testing in an unselected population
por: Cochran, Meagan, et al.
Publicado: (2021)

Validation of a Simple Score for Mortality Prediction in a Cohort of Unselected Emergency Patients
por: Busch, Jeannette-Marie, et al.
Publicado: (2022)

Enhancing the interpretation of genetic observations in KCNQ1 in unselected populations: relevance to secondary findings
por: Novelli, Valeria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pg1tmc37m3o3fk8dv0q4c5ooqv